Fiona McCann

Fiona McCann is an accomplished immunologist with over twenty years of experience in the field. Currently serving as the Associate Director of Pipeline Biology for Autoimmune indications at Immunocore, Fiona leads preclinical activities focused on autoimmune disorders. Prior to this role, Fiona worked as a Scientific Director at 180 Life Sciences, managing a pre-clinical drug discovery platform for novel cannabinoids aimed at pain and inflammation treatment. Fiona's extensive background includes directing early discovery at CannBioRex Life Sciences, leading a Translational Immunology group at the Kennedy Institute, and conducting mechanistic studies as a Post-Doctoral Fellow and Researcher at prestigious institutions. Academic credentials include a Ph.D. from the University of Oxford and a Master's degree from Queen's University Belfast.